Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: A case series

Breast Cancer Research

Volumn 15, Issue 5, 2013, Pages

  McCormack, Valerie A ^a   Joffe, Maureen ^b   van den Berg, Eunice ^c   Broeze, Nadine ^b   dos Santos Silva, Isabel ^d   Romieu, Isabelle ^a   Jacobson, Judith S ^e   Neugut, Alfred I ^e   Schüz, Joachim ^a   Cubasch, Herbert ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER STAGING; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PUBLIC HOSPITAL; RACE DIFFERENCE; SOUTH AFRICA; TRIPLE NEGATIVE BREAST CANCER; AGE; AGED; BLACK PERSON; CANCER PATIENT; CASE STUDY; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGICAL DATA; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; GLOBAL DISEASE BURDEN; RACE; RISK ASSESSMENT; SOUTH AFRICAN; TREND STUDY; BREAST TUMOR; CANCER GRADING; METABOLISM; MIDDLE AGED; PATHOLOGY; POPULATION GROUP; TIME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POPULATION GROUPS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEER PROGRAM; SOUTH AFRICA; TIME FACTORS; TRIPLE NEGATIVE BREAST NEOPLASMS; YOUNG ADULT;

EID: 84883893097     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3478     Document Type: Article

References (28)

1. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de RM, Perou CM. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374. 10.1158/1078-0432.CCR-04-0220, 15328174.
2. Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752. 10.1038/35021093, 10963602.
3. Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 2008, 110:183-188. 10.1007/s10549-007-9694-5, 17674190.
4. Awadelkarim KD, Arizzi C, Elamin EO, Hamad HM, De BP, Mekki SO, Osman I, Biunno I, Elwali NE, Mariani-Costantini R, Barberis MC. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 2008, 52:445-456. 10.1111/j.1365-2559.2008.02966.x, 18315597.
5. Basro S, Apffelstaedt JP. Breast cancer in young women in a limited-resource environment. World J Surg 2010, 34:1427-1433. 10.1007/s00268-009-0299-5, 19997919.
6. Bird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?. Ann Surg Oncol 2008, 15:1983-1988. 10.1245/s10434-008-9900-7, 18408976.
7. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, Falusi A, Perou CM, Olopade OI. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009, 27:4515-4521. 10.1200/JCO.2008.19.6873, 2754904, 19704069.
8. Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res 2002, 22:3005-3012.
9. Stark A, Kleer CG, Martin I, Awuah B, Nsiah-Asare A, Takyi V, Braman M, Quayson SE, Zarbo R, Wicha M, Newman L. African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 2010, 116:4926-4932. 10.1002/cncr.25276, 3138711, 20629078.
10. Anderson WF, Katki HA, Rosenberg PS. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 2011, 103:1397-1402. 10.1093/jnci/djr257, 3176776, 21753181.
11. Jemal A, Fedewa SA. Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than US-born black women?. Breast Cancer Res Treat 2012, 135:867-873. 10.1007/s10549-012-2214-2, 22915073.
12. Yaziji H, Taylor CR, Goldstein NS, Dabbs DJ, Hammond EH, Hewlett B, Floyd AD, Barry TS, Martin AW, Badve S, Baehner F, Cartun RW, Eisen RN, Swanson PE, Hewitt SM, Vyberg M, Hicks DG. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol 2008, 16:513-520. 10.1097/PAI.0b013e31818a9d3a, 18931614.
13. Fergenbaum JH, Garcia-Closas M, Hewitt SM, Lissowska J, Sakoda LC, Sherman ME. Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol Biomarkers Prev 2004, 13:667-672.
14. Committee of Enquiry, Health Chapter Policy Options for the Future Covering. Chapter 2: South Africa Health System: A Review 2002, Department of Health, Republic of South Africa, Committee of Enquiry, Health Chapter.
15. Statistics South Africa, http://www.statssa.gov.za, Statistics South Africa.
16. Owens MA, Horten BC, Da Silva MM. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer 2004, 5:63-69. 10.3816/CBC.2004.n.011, 15140287.
17. Anderson WF, Luo S, Chatterjee N, Rosenberg PS, Matsuno RK, Goodman MT, Hernandez BY, Reichman M, Dolled-Filhart MP, O'Regan RM, Garcia-Closas M, Perou CM, Jatoi I, Cartun RW, Sherman ME. Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat 2009, 113:189-196. 10.1007/s10549-008-9918-3, 2676874, 18256926.
18. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295:2492-2502. 10.1001/jama.295.21.2492, 16757721.
19. Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence, SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2010 Sub (1973-2008 varying), Linked To County Attributes 2010, Total U.S., 1969-2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch released April 2011 (updated 10/28/2011), based on the November 2010 submission. 2010. Ref Type: Report.
20. Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat 2002, 76:27-36. 10.1023/A:1020299707510, 12408373.
21. Anderson WF, Matsuno R. Breast cancer heterogeneity: a mixture of at least two main types?. J Natl Cancer Inst 2006, 98:948-951. 10.1093/jnci/djj295, 16849671.
22. Rubin D. Multiple Imputation for Nonresponse in Surveys 1987, New York: Wiley.
23. Gukas ID, Jennings BA, Mandong BM, Igun GO, Girling AC, Manasseh AN, Ugwu BT, Leinster SJ. Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med 2005, 24:209-213.
24. Macfarlane R, Seal M, Speers C, Woods R, Masoudi H, Aparicio S, Chia SK. Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor. Oncologist 2012, 17:172-178. 10.1634/theoncologist.2011-0127, 3286165, 22267852.
25. Moultrie TA, Timaeus IM. The South African fertility decline: evidence from two censuses and a demographic and health survey. Popul Stud (Cambridge) 2003, 57:265-283.
26. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003, 21:28-34. 10.1200/JCO.2003.03.088, 12506166.
27. StatBite JNCI. StatBite: breast cancer: 5-year survival rates in U.S. for selected histologic types by stage. J Natl Cancer Inst 2009, 101:1303. Ref Type: Report.
28. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999, 91:2020-2028. 10.1093/jnci/91.23.2020, 10580027.